Eisai
4523.T
#2336
Rank
C$11.10 B
Marketcap
C$39.41
Share price
0.77%
Change (1 day)
-0.62%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): C$1.17

According to Eisai's latest financial reports the company's current EPS (TTM) is C$1.18. an increase over its 2024 EPS that were of C$1.33.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2025C$1.4911.85%
2024C$1.33-32.63%
2023C$1.985.52%
2022C$1.88-74.01%
2021C$7.22-66.58%
2020C$21.5998.24%
2019C$10.8917.01%
2018C$9.3137.78%
2017C$6.76-27.62%
2016C$9.3335.33%
2015C$6.90-2.82%
2014C$7.10-27.66%
2013C$9.81-27.49%
2012C$13.53-12.67%
2011C$15.5088.08%
2010C$8.24-11.06%
2009C$9.26-390.15%
2008C-$3.19-127.78%
2007C$11.4911.78%
2006C$10.284.38%
2005C$9.857.4%
2004C$9.1743.03%
2003C$6.4125.09%
2002C$5.1352.67%
2001C$3.3669.76%
2000C$1.98